← #nieuws

EU Biotech Act call for evidence: four asks to make biotech thrive 

, ,

Europe worked hard to become a leader in biotech. But while the rest of the world is taking the next step, we are blocking ourselves. Innovations get stuck in outdated rules and fragmented regulations, talent moves elsewhere, and other continents capitalize on European breakthroughs. If we don’t act now, Europe not only loses its frontrunner’s position, but also the societal and economic benefits that biotech can deliver: new medicines, smarter and cleaner products and a resilient economy.  

While the US and China are competing over pole position, the EU aims to step up its game when it comes to biotech, too. The EU Biotech Act, to be launched next year, is one the instruments to reinstate Europe as a biotech powerhouse. At hollandbio, we welcome the EU Biotech Act as a long-awaited opportunity to restore Europe’s leadership in biotechnology and strengthen our biotech innovation ecosystem—from invention all the way to uptake.   

In our overarching EU Biotech Act position paper, we state what we think is needed to ensure European biotech can thrive. Building on this, hollandbio submitted four key asks for the European Commission’s recent Call for Evidence, a consultation to gather input from stakeholders and experts to shape the EU Biotech Act legislative proposal. 

To ensure biotech can thrive in Europe, we urge policymakers to focus on four key priorities

  • Boosting biotech with an integrated approach; 
  • Investing in progress driven by frontrunners; 
  • Paving the way to market entry; 
  • Removing barriers for implementation and uptake. 

In these uncertain time, one thing is clear: the coming years are of crucial importance for the success of biotech. From curing incurable diseases to creating eco-friendly materials and ensuring food security, if we want to pass on a livable world to future generations, biotech is an essential part of the solution.  

What would you act for? 

Have you ever faced funding gaps, regulatory delays, or an uneven playing field? Then this is your moment to speak up! Share your vision for the future of European biotech by joining the conversation on LinkedIn by using #EUBiotechAct.